Satellite Session: Results from the Early Routine Use of Point-of-Care HIV Testing in Resource-Limited Settings

Session Presentations

Satellite 1: Integrating Diagnostic Services at Point of Care:

Access to HIV diagnostics to determine and monitor HIV infection is one of the major bottlenecks to timely treatment initiation in children and adults, as well as to contain the community spread in at risk populations. Molecular diagnostics for Early Infant Diagnosis (EID), Viral Load monitoring and screening for acute infections usually require complex technologies that ultimately lead to delays in results availability. These delays negatively impact treatment initiation, linkage to care and spread containment. A simple molecular technology like GeneXpert that can be used at point-of-care delivering on-demand timely results, can help to close these gaps that currently lead to poorer health outcomes, higher treatment costs, and further spread of disease. In addition to this, the possibility to use the same GeneXpert platform to perform different tests such as HIV, TB, HCV, CT/NG and HPV provides the opportunity to develop integrated diagnostic programs at the Point of Impact.


  1. Accuracy and operational feasibility of Xpert® HIV-1 Qual* point-of-care testing in HIV-infected mothers and their infants during birth in Tanzania – outcome from the Baby Study. Arne Kroidl, University of Munich, LMU, Germany (Slides will be available soon)
  2. Xpert® HIV-1 Viral Load: Beyond Plasma. Lara Noble, University of the Witwatersrand, South Africa (Slides will be available soon)
  3. HIV and TB Integration Phase 1 Implementation Experiences from Zimbabwe
    Raiva Simbi, Ministry of Health and Child Care Zimbabwe, Zimbabwe (Slides will be available soon)
  4. WHO Prequalification of in-vitro diagnostics: Xpert® HIV-1 Viral Load* with the GeneXpert® System
    Gwynn Stevens, Cepheid, South (Slides will be available soon)
  5. Early diagnosis of HIV and use of the GeneXpert System as part of a comprehensive strategy to end HIV transmission
    Michael Meulbroeck, BCN Checkpoint, Spain (Slides will be available soon)
  6. A pilot evaluation of whole blood nger-prick sampling for point-of-care HIV viral load measurement: the UNICORN study
    John Frater, Oxford University, United Kingdom (Slides will be available soon)

Presentation 1 (Slides will be available soon)

Presentation 2 (Slides will be available soon)

Satellite 2: Bringing the Test to the Patient: Results from the Early Routine Use of Point-of-Care HIV Testing in Resource-Limited Settings

With the availability of effective Point-of-Care (POC) molecular technology for Early Infant Diagnosis (EID) and viral load (VL) testing, ministries of health (MOHs), along with partners, have begun to implement routine POC testing in an effort to optimize laboratory networks and improve clinical outcomes. This session, featuring presentations by MOH officials and partners, will focus on sharing best practices and early results from research and routine use of POC molecular testing. Topics will include deployment strategies, maximizing the capacity of POC devices to perform multiple tests, including tuberculosis and hepatitis C (HCV), the experience of implementing routine POC testing for Early Infant Diagnosis (EID), the projected potential impacts of implementing the WHO recommendations for POC EID testing (WHO Consolidated Guidelines, June 2016), and the use of connectivity for remote monitoring of decentralized testing networks.


  1. Introduction Video
    Smiljka de Lussigny, Unitaid, Switzerland (Video will be available soon)
  2. Comparing Conventional to Point-of-Care (POC) Early Infant Diagnosis (EID): Pre and post intervention data from a multi-country evaluation Flavia Bianchi, Elizabeth Glaser Pediatric AIDS Foundation, United States
  3. Leveraging excess GeneXpert capacity to integrate HIV and TB testing services: A case study from Zimbabwe
    Raiva Simbi, Ministry of Health and Child Care Zimbabwe, Zimbabwe
  4. Tracking manufacturer performance to ensure uninterrupted provision of timely, high quality EID test results
    Esther Turunga, Elizabeth Glaser Pediatric AIDS Foundation, Switzerland
  5. Routine use of point-of-care EID testing in Côte d’Ivoire: Early lessons learnt
    Patricia Fassinou, Elizabeth Glaser Pediatric AIDS Foundation, Cote D’Ivoire
  6. Patient impact and financial impact of implementing recommended WHO EID testing algorithm – at/near-birth testing, entry points, and POC
    Jenna Mezhrahid, Clinton Health Access Initiative, South Africa
  7. Using data to monitor POC device performance and error rates
    Chishamiso Mudenyanga, Clinton Health Access Initiative, Mozambique

Point-of-Care-related abstracts from IAS

Title Type Abstract link
1 Use of FACSPresto? for measurement of CD4 and haemoglobin in resource-limited settings Poster
2 Detection and confirmation of HIV-2 presence in Brazil: surveillance algorithm in indene area Poster
3 Viral load monitoring with SAMBA-1, a semi-quantitative nearly point-of-care method in Arua, a rural district in Uganda Poster
4 Implementation of point-of-care (POC) HIV viral load (VL) monitoring during antenatal care at a primary care clinic in Cape Town, South Africa Poster
5 Will HIV test and start be the end of baseline CD4 monitoring? CD4 functionality and impact of transition in a resource-limited setting, Zimbabwe Poster
6 The clinical impact and cost-effectiveness of incorporating point-of-care (POC) assays into early infant HIV diagnosis (EID) programs at 6 weeks of age in Zimbabwe: a model-based analysis Oral
7 A pilot evaluation of whole blood finger-prick sampling for rapid and convenient point-of-care HIV viral load measurement: the UNICORN study Poster
8 PoCT (point of care) HIV/STI testing at after-hours SOPV (sex on premises venues) theme parties Poster
9 Performance of the point of care Cepheid GeneXpert HIV qual for early infant diagnosis: field experience in Kenya Poster
10 Point-of-care HIV viral load testing: suitable performance with AlereTMq 50µl plasma cartridge Poster
11 Testing and linkage to care for injecting drug users (TLC-IDU) in Kenya: a baseline assessment in western region Poster
12 Integrating pediatric HIV diagnosis with relevant health programs for optimal pediatric HIV uptake Poster
13 Cost-effectiveness of external quality assurance to prevent early infant mis-diagnosis of HIV in 4 African countries Poster
14 Costs of HIV viral load testing using POC and central laboratories: assessing an efficient viral load testing network in Kenya Poster